|
|
Post by hellodolly on Dec 3, 2019 15:20:26 GMT -5
Slide deck not up yet. Who else is listening?
|
|
|
|
Post by theshiv on Dec 3, 2019 15:27:11 GMT -5
Present.
|
|
|
|
Post by goyocafe on Dec 3, 2019 15:30:50 GMT -5
The message on the screen says "Audio Presentation Only". Will we get slides?
|
|
|
|
Post by theshiv on Dec 3, 2019 15:33:01 GMT -5
The message on the screen says "Audio Presentation Only". Will we get slides? Slides appear ready to go from here. |
|
|
|
Post by racedog on Dec 3, 2019 15:35:42 GMT -5
Link?
|
|
|
|
Post by sla55 on Dec 3, 2019 15:36:57 GMT -5
|
|
|
|
Post by theshiv on Dec 3, 2019 15:37:24 GMT -5
Sorry, looks like slides not available, missed that. |
|
|
|
Post by racedog on Dec 3, 2019 15:45:09 GMT -5
Thanks  |
|
|
|
Post by goyocafe on Dec 3, 2019 15:59:09 GMT -5
A trip to NYC for that? What did that just cost us?
|
|
|
|
Post by awesomo on Dec 3, 2019 16:09:07 GMT -5
Sounds like Mike is resting, while his bank account is growing.
|
|
|
|
Post by brotherm1 on Dec 3, 2019 16:20:58 GMT -5
Something was said about pediatric trial reduced to 26 instead of 52 weeks if I heard correctly at work?
|
|
|
|
Post by goyocafe on Dec 3, 2019 16:31:01 GMT -5
Something was said about pediatric trial reduced to 26 instead of 52 weeks if I heard correctly at work? That's what I heard, and that they have already been approved to proceed to the Phase III trial without completing the final cohort of Phase II. I must be dreaming, because that kind of news would definitely be shared with shareholders. Right?! Or I'm dreaming, and I misunderstood the audio. |
|
|
|
Post by brotherm1 on Dec 3, 2019 16:50:22 GMT -5
I thought I heard the same: moving right into phase three
|
|
|
|
Post by mango on Dec 3, 2019 16:54:12 GMT -5
Something was said about pediatric trial reduced to 26 instead of 52 weeks if I heard correctly at work? That's what I heard, and that they have already been approved to proceed to the Phase III trial without completing the final cohort of Phase II. I must be dreaming, because that kind of news would definitely be shared with shareholders. Right?! Or I'm dreaming, and I misunderstood the audio. I have not listened to the webcast yet, but based on what you’re telling me, the peds clinical trial has apparently been going so exceptionally well and exceeding expectations, showing tremendous positive results thus far, that FDA has granted MannKind a faster route to completion. But, that’s just mytakeonit 🕺🏻 |
|
|
|
Post by wyattdog on Dec 3, 2019 17:03:22 GMT -5
what i heard was there was 2 parts,part 1 was dosing part 2 was a phase 3 study. fda agreed to end part 1 and let them proceed to phase 3 hoping to reduce the end point to 26wks instead of 52wks.
|
|
